Drug Development at the Portfolio Level Is Important for Policy, Care Decisions and Human Protections

Abstract

This Viewpoint discusses the drug development portfolio—a family of trials assessing a drug for different indications or in different combinations with other drugs—and summarizes some of the challenges drug portfolios pose for policy, care, and human protections.